Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update

被引：82

作者：

Ardissino, Gianluigi ^{[1
]}

Possenti, Ilaria ^{[1
]}

Tel, Francesca ^{[1
]}

Testa, Sara ^{[1
]}

Salardi, Stefania ^{[1
]}

Ladisa, Vito ^{[1
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr HUS Control, Prevent & Management, Milan, Italy

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 66卷 / 01期

关键词：

D O I：

10.1053/j.ajkd.2015.04.010

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：172 / 173

页数：3

共 2 条

[1] Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases [J].

Ardissino, Gianluigi ;

Testa, Sara ;

Possenti, Ilaria ;

Tel, Francesca ;

Paglialonga, Fabio ;

Salardi, Stefania ;

Tedeschi, Silvana ;

Belingheri, Mirco ;

Cugno, Massimo .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (04) :633-637

[2] Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome [J].

Cugno, M. ;

Gualtierotti, R. ;

Possenti, I. ;

Testa, S. ;

Tel, F. ;

Griffini, S. ;

Grovetti, E. ;

Tedeschi, S. ;

Salardi, S. ;

Cresseri, D. ;

Messa, P. ;

Ardissino, G. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) :1440-1448

← 1 →